33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-4.57
Both companies show losses. Martin Whitman would check if industry conditions create special situations.
36.77
P/S 50-75% of PATH's 65.88. Bruce Berkowitz would examine if sales quality justifies the gap.
4.68
P/B less than half of PATH's 9.93. David Dodd would verify if asset quality justifies this discount.
-80.13
Both companies show negative FCF. Martin Whitman would check for industry-wide capital intensity issues.
-95.72
Both companies show negative operating cash flow. Martin Whitman would check for industry-wide operational issues.
4.68
Fair value ratio less than half of PATH's 9.93. David Dodd would verify if competitive position justifies this discount.
-5.47%
Both companies show losses. Martin Whitman would check for industry-wide issues.
-1.25%
Both companies show negative FCF. Martin Whitman would check for industry-wide capital intensity issues.